Last reviewed · How we verify

NCT06189105

Efficacy and Safety Assessment of Niacinamide Cosmetic Preparation: a Randomized Controlled Trial

Status unknown NA Last updated 3 January 2024
What this trial tests

NA trial testing miss alice face it you love me serum in Skin Hyperpigmentation in 25 participants. Status unknown.

Timeline
3 June 2023
Primary endpoint
1 June 2024
1 June 2024

Quick facts

Lead sponsorUniversity of Split, School of Medicine
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designsingle group
Maskingtriple
Primary purposetreatment
Enrollment25
Start date3 June 2023
Primary completion1 June 2024
Estimated completion1 June 2024
Sites1 location across Croatia

Drugs / interventions tested

Conditions studied

Sponsor

University of Split, School of Medicine

Who can join

Eligibility, any sex, with Skin Hyperpigmentation or Dry Skin; Eczema. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Niacinamide in lower concentrations has been recognized as a cosmetic ingredient with hydrating properties. Therefore, aim was to test the efficacy and safety of niacinamide cosmetic preparation in A Randomized, Controlled Trial.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

  1. Clinical Measurement of Transepidermal Water Loss.
    Kundu D, Jayaraman A, Sen CK. · · 2026 · cited 4× · PMID 40476522 · DOI 10.1089/wound.2024.0148
  2. Pilot Study on the Effects of a Cosmetic Serum Containing Niacinamide, Postbiotics and Peptides on Facial Skin in Healthy Participants: A Randomized Controlled Trial.
    Rusic D, Ivic M, Slugan A, Leskur D, et al · · 2024 · cited 1× · PMID 39768384 · DOI 10.3390/life14121677

Verify or expand the search:

Other University of Split, School of Medicine trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06189105.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing